High Prevalence of Osteonecrosis to Augment Growth of Osteonecrosis Treatment Market

Osteonecrosis is a medical term meaning "bone death." It is caused by an inflammation of the hip joint due to a reduction in blood supply. This type of bone disease can have an extensive impact on the quality of life of individuals suffering from it, making the treatment of osteonecrosis extremely important.

Market Dynamics

High prevalence of osteonecrosis is expected to propel growth of the osteonecrosis treatment market. For instance, according to the study, ‘Epidemiology of osteonecrosis among older adults in Sweden’, published in Springer in January 2019, the 10-year risk of osteonecrosis was 0.4% and the incidence rate was 4.7 cases/10000 person-years. Moreover, high prevalence of osteoporosis is also expected to aid in growth of the osteonecrosis treatment market. For instance, according to a study published online in February 2020 in the Journal of Clinical Endocrinology & Metabolism, for denosumab-treated women with postmenopausal osteoporosis, invasive oral procedures and events (OPEs), including dental implants, tooth extraction, natural tooth loss, scaling/root planning, and jaw surgery, are common and associated with osteonecrosis of the jaw.

High prevalence of cancer is expected to offer lucrative growth opportunities for players in the osteonecrosis treatment market. For instance, in December 2020, a study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and published in JAMA Oncology, found that 2.8 percent of patients on average develop osteonecrosis of the jaw, within three years of starting a common treatment for cancer that has spread to the bone. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Among regions, North America is expected to witness significant growth in the osteonecrosis treatment market, owing to high prevalence of cancer. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Competitive Analysis

Major players operating in the osteonecrosis treatment market include, Bone Health, Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co Ltd.

Major players operating in the osteonecrosis treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2020, Bone Health’s OsteoBoost received the U.S FDA’s Breakthrough Device Designation to reduce the risk of osteoporosis.

Comments

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.

Increasing Prevalence of Chronic Diseases to Augment the Smart Home Medical Device Market Growth

The use of Internet-of-Things (IoT) in healthcare is represented through smart medical equipment. Many of the issues preventing the effective provision of healthcare to people all around the world are resolved by these gadgets. Smart healthcare technologies also improve the quality and length of human life in addition to smart home medical devices . Growing internet penetration favors growth of smart home medical devices market : The most cutting-edge and futuristic method of making life simpler and safer is the smart home medical device. This ground-breaking move by the medical equipment manufacturer has had a favourable impact on the healthcare sector and the rate of technological adoption. The situation is rapidly changing, with greater acceptance rates of such devices, a trend that is likely to continue during the forecast period, despite the fact that the majority of consumers and healthcare organisations were first suspicious of the technology.

Healthcare News

Search This Blog